Track Wockhardt Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -1.62 %
Low
1,876.6
High
1,994.0
1 Month returns: -7.00 %
Low
1,820.0
High
2,178.0
1 Year returns: 10.58 %
Low
1,086.7
High
2,422.3
3 Year CAGR: 101.29 %
Low
213.3
High
2,422.3
5 Year CAGR: 31.31 %
Low
145.2
High
2,422.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Wockhardt Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Wockhardt Ltd. Shareholding Pattern
Quarterly breakdown of Wockhardt Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Wockhardt Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Wockhardt Ltd.?
The current share price of Wockhardt Ltd. is ₹ 1,942.10 as of 3 Jul 2026.
What is the market capitalisation of Wockhardt Ltd.?
The market capitalisation of Wockhardt Ltd. stands at ₹ 31,685.90 Cr.
What is the PE ratio of Wockhardt Ltd.?
The Price-to-Earnings (PE) ratio of Wockhardt Ltd. is 148.76 as of the latest trailing twelve months data.
What is the ROE and ROCE of Wockhardt Ltd.?
Wockhardt Ltd. has a Return on Equity (ROE) of 4.58% and a Return on Capital Employed (ROCE) of 5.67% as per the latest financial reports.
What is the 52-week high and low of Wockhardt Ltd.?
The 52-week high of Wockhardt Ltd. is - and the 52-week low is -.
What is the dividend yield of Wockhardt Ltd.?
The dividend yield of Wockhardt Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Wockhardt Ltd.?
Foreign Institutional Investors (FII) hold 7.09%, Domestic Institutional Investors (DII) hold 8.18% and retail/public investors hold 30.23% of Wockhardt Ltd. shares.
What sector does Wockhardt Ltd. belong to?
Wockhardt Ltd. operates in the Healthcare sector.
What is the beta of Wockhardt Ltd.?
The beta of Wockhardt Ltd. is 0.75, indicating its price volatility relative to the broader market. Over the past 1 year, Wockhardt Ltd. has delivered an absolute return of 12.70%.
What is the RSI of Wockhardt Ltd.?
The 14-day Relative Strength Index (RSI) of Wockhardt Ltd. is 55.70, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Wockhardt Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 81.5 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
81.5 / 100
Moderate operating margin but improving trend
The company reported moderate operating margin of 11.95% for 12-month ended 31 Mar 2026 but operating margin improved by 596 bps from 1 year ago
What is Operating profit margin?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.46 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year
What is Debt to Equity?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 148.76 indicates that the stock is expensive on a standalone basis and is at a 391.61% premium to industry median P/E
What is P/E Ratio?
Median: 30.26
Value 148.76
-215.443183
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Low ROE but improving trend
The company reported low ROE of 4.58% for 12-month ended 31 Mar 2026 but ROE improved by 580 bps from 1 year ago
What is ROE (FY)?
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 11.99% for 12-month ended 31 Mar 2026 and the growth was 0.75 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 11.24
Value 11.99
-82.35114662
Company's earnings are of moderate quality
Earnings quality score of 58.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
58.6 / 100
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Overview of Wockhardt Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL 500 MCG 15T, METHYCOBAL INJ 1 ML, METHYCOBAL D 10T, HAPID 10C, PROXYFEN NANO GEL, LIVATIRA 500 10T NEW PACK, LIVATIRA INJ 5 ml, GABAWOK NT 100MG 15T, GABAWOK NT 400MG 15T, ETOBRIX 90 MG 10C, ETOBRIX TH 4 10C, ETOBRIX P 10T, GLARZEN 100IU, TERITIDE, GLIMADAY HS, GLIMADAY FORTE-2, GLIMADAY FORTE-1, GLIMADAY FORTE 3, GLIMADAY 2 mg, GLIMADAY 1 mg, MOPADAY FORTE, INOGLA, WEPOX 4000 IU 1ML, MYCORAL M, Val 450, OKERON INJ 100MCG 1ML, DARBOTIN 40, and DARBOTIN 60.
Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generi...